Stocks To Buy Now Blog

All posts by Christopher

American Cannabis Partners’ Strict Adherence to Jamaican Cultivation Techniques Results in Much Sought-After Flower

  • Jamaican cannabis has benefitted from burgeoning global demand in 2021, with the regulator issuing 42 export licenses
  • American Cannabis Partners has sought to capitalize on growing demand for Jamaican cannabis through a strict adherence to Jamaican cultivation techniques given its close links to the nation
  • US cannabis cultivators are gradually increasing their focus on product differentiation to gain market share within the rapidly growing sector
For Jamaican cannabis cultivators, business is booming. The nation’s industry regulator, the Cannabis Licensing Authority (“CLA”), recently revealed that it had witnessed a dramatic uptick in demand for Jamaican ‘ganja’ on the global market, having issued export licenses to territories as far away as Australia and Germany in recent months, both of which were seeking to import Jamaican cannabis for research and medical purposes. In total, the CLA stated, the regulator had issued 42 export authorizations to 10 entities trading with various regions across the globe thus far this year (https://ibn.fm/9rnFP). “What this tells us is that we have been producing cannabis to the standards required of these other jurisdictions and therefore there is potential for commercial quantities to be exported in the future once markets are opened,” said acting CLA head, Faith Graham. American Cannabis Partners (“ACP”), a multi-state 100% organic cannabis cultivation company headquartered within Northern California’s Emerald Triangle, has sought to capitalize on the global affinity for Jamaican cannabis as well as its close links to the nation through the employment of traditional Jamaican cultivation techniques within their cannabis cultivation, harvesting and curing process. The methods in turn, have resulted in a far superior product for the company, as well as faster growth rates, greater production yields, higher THC levels, and enhanced terpene bouquets (https://ibn.fm/rEUtl). The level of exacting detail and care paid to its plants, as well as its adherence to sustainable Jamaican production practices, have led the company to produce some of the most sought-after flower in the United States, with ACP recently revealing that its new, patent-pending strains marketed under its wholly owned in-house ZUK brand had already seen its entire crop presold for 2021. The U.S. cannabis market has the potential to touch an annual value of $115 billion by 2030 according to Michael Lavery, a senior research analyst at investment bank Piper Sandler, rising from sales of $17.5 billion last year. However, and in a rapidly growing marketplace, Lavery believes that product differentiation will increasingly drive the fortunes and pricing power of the numerous players within the sector (https://ibn.fm/YtMa2). “In this space now, it’s really scarcity that’s driving the value and we see that in every market,” Lavery explained. Cannabis plants habitually produce hundreds of aromatic terpenes, which have been shown to influence both a cannabis plant’s psychoactive properties as well as driving end-consumer demand. American Cannabis Partners has sought to cater to the rapidly evolving consumption tastes of their U.S. audience by way of its meticulous focus on cultivation practices as well as its unique focus on Jamaican techniques, methods which have enabled the company to produce and market a differentiated, niche-market product. Through the adoption of a business model that prizes quality and diversity of its organic end-product above all else, American Cannabis Partners has taken the initial steps towards boosting the company’s profile and competitiveness ahead of a fully legalized U.S. cannabis market. For more information, visit the company’s website at www.ACPFarms.com. NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://ibn.fm/ACP

FuelPositive Corp (TSX.V: NHHH) (OTCQB: NHHHF) Issues Costing Model and Timeline for Proprietary Green Ammonia Production System

  • FuelPositive’s green ammonia production system is affordable, practical, and about to be available for “real-world” applications in the very near future
  • According to the company’s case study, it costs CA$560 to produce one metric tonne of green anhydrous ammonia in Manitoba using its system, compared to the current average Manitoba delivery cost of CA$900 per metric tonne of grey ammonia
  • Having commenced development of the first prototype in June of 2021, FuelPositive has begun the building of its second and third prototypes
  • It expects to deploy pilot systems throughout 2022
  • FuelPositive expects serial manufacturing to begin in 2023 as batch sizes increase
For FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a growth-stage technology company committed to clean energy solutions, 2021 has so far been incredible. Occasioned by the marked progress in the development of its unique modular, scalable system for producing green ammonia (“NH3”), this phenomenal year has steered the company toward the scheduled launch of multiple “real-world” demonstration pilots to showcase its technology throughout 2022, as well as commercialization of its flagship product. In a recent update, FuelPositive released an operational costing model and aggressive timeline to be first to market, both critical to its product’s commercialization (https://ibn.fm/RbXSl). “We are highly efficient, knowledgeable, and experienced in every step we need to take along the way to commercialization. We can move much more quickly than our competitors, and that is one of our great strengths,” commented Ian Clifford, CEO and Board Chairperson of FuelPositive. To come up with a costing model, FuelPositive used a 1,800-acre case study farm in Manitoba, Canada, a province powered by a carbon-free, sustainable electricity grid. As a result, the company established that the cost of producing green ammonia using its system was CA$560 per metric tonne (based on a hydrogen production efficiency rate of 65%), compared to a current average delivery cost of CA$900 per metric tonne of traditionally produced (“grey”) ammonia – a 37.8% decrease. The lower cost, according to a recent Recharge article (https://ibn.fm/ARNZW), is based on the fact that “FuelPositive will combine electrolyzers (which split water molecules into hydrogen and oxygen) with a proprietary reactor that combines nitrogen from the air with H2 using ‘much lower temperatures and much lower pressure’ than Haber-Bosch, resulting in 40% lower costs.” Notably, Haber-Bosch, the production process behind grey ammonia, is energy intensive – needing pressures above 100 bar and temperatures of between 400-500°C. In addition, because the traditional system is powered by fossil fuels, it contributes roughly 1% of the total global carbon emissions annually. If the CO2 emissions from grey hydrogen production (which also relies on fossil fuels), at a rate of 9-18 tons of CO2 for every ton of H2 generated, are taken into account, the quoted emissions from traditional ammonia production are bound to increase even further. In this regard, FuelPositive’s system will substantially reduce overall production and distribution -related emissions. FuelPositive’s calculations are based on Manitoba’s current electricity cost of CAD 0.045/kWh, the largest contributor to the overall production cost of its system. Even so, the total figure does not consider any potential cost reductions as a result of carbon credits or the farmers’ capacity to generate sustainable electricity through on-site solar or wind power generation. The company’s system can produce up to 300 kilograms (500 liters) of green anhydrous ammonia daily, totaling about 100 tonnes per year, an output that is suitable for the 1800-acre model farm. For larger farms, FuelPositive contends that farm owners could simply add sufficient production capacity, aided by the green ammonia production units’ modular, scalable and portable nature. In addition to having a stable, predictable and highly competitive cost per metric tonne, FuelPositive’s green ammonia production system offers independence from the unpredictable fluctuations of grey anhydrous ammonia today. For instance, in just six months, the delivery cost of grey ammonia to Manitoba farmers doubled from C $600 to CA$1,200, resulting in the CA$900 average cost used in the FuelPositive’s costing calculations. Moreover, according to Recharge, FuelPositive’s system will offer farmers and other users additional advantages. For instance, the company is evaluating an ion-exchange membrane (“AEM”) electrolyzers, “which do not require the purified H2O normally required for electrolysis – instead, simple tap water can be used. And that electrolyzer could even be modified to use seawater.” At the same time, green ammonia could provide fuel for the grain-drying process, which is often powered by natural gas or propane – further decreasing CO2 emissions and costs. FuelPositive, which started building its first full-sized prototype system in June this year, immediately after filing for its provisional patent, is already beginning to build the second and third prototypes, applying a batch-style approach to manufacturing. By the beginning of spring next year, the NHHH team expects to be validating the purity of the green ammonia produced by the first prototype system, as well as its operating expenditure (“OPEX”) figures, at which point pre-orders will begin. The company anticipates deploying the first three pilot systems throughout 2022. As batch sizes increase, FuelPositive expects serial manufacturing to begin in 2023. “We are at a point now where we are comfortable with our forecasts. If we have any significant delays or changes, we will communicate that and explain what we are doing about it,” said Nelson Leite, NHHH’s Chief Operating Officer. For more information, visit the company’s website at www.FuelPositive.com. NOTE TO INVESTORS: The latest news and updates relating to NHHHF are available in the company’s newsroom at https://ibn.fm/NHHHF

As Older Population Starts Self-Directed Investing, O&G Company Engages SRAX Inc. (NASDAQ: SRAX) for Targeted Outreach

  • Charles Schwab survey shows 15% of retail investors started during the COVID-19 pandemic in 2020
  • SRAX’s Sequire premier IR communications platform assists public companies understand and communicate with the investment community
  • After following SRAX to understand its expertise, Sino American Oil Company has engaged SRAX
  • More than 250 companies now use Sequire, driving revenue to $8.3 million in Q3 and on the way to the high-end of 2021 guidance
The coronavirus pandemic changed many things in the world, and you can be sure investing is on the list. According to a Charles Schwab survey earlier this year, about 15 percent of today’s retail investor population got started in 2020, a group Schwab has labeled “Generation Investor.” In the survey of about 1,000 people, Schwab also learned that investing respondents are taking a long approach and that it isn’t just younger generations putting their money in the market, a mix that bodes well for communications specialists like SRAX (NASDAQ: SRAX). SRAX is a diversified financial technology, digital marketing and consumer data management company that provides an array of consumer data to its clients valuable to marketing and communications. SRAX’s flagship offering is a premier investor intelligence and communications platform branded Sequire. In September 2020, SRAX also completed the acquisition of LD Micro, arguably the best-known name in data and events serving the small and microcap markets. Schwab’s research discovered a median age of 35 for Generation Investor, comprised of about 11% Baby Boomers, 16% Generation Z, 22% Generations X and the remainder being Millennials. SRAX’s technology unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools, and data-driven marketing. Looking to leverage the SRAX technology to assist with its investor outreach and growth initiatives, oil and gas explorer, Sino American Oil Company (OTCPK: OILY), engaged SRAX this month to better understand its investors and target them in an efficient manner. The partnership will allow Sino American Oil to optimize marketing and communications strategies to reach out to consumers, shareholders, and investors. According to Sino American Oil CEO Kim Halvorson, the company did its due diligence before partnering with SRAX. “We have been following SRAX for some time now, they’re expertise in the Oil and Gas sector and the digital marketing has been impressive,” said Halvorson. Expanding its offerings, SRAX recently launched an IR Website Builder, SMS feature and VIRA, and an IR chatbot. This has translated to a strong improvement in revenue, which rose 219% year-over-year in the third quarter to $8.3 million. With Q4 bookings exceeding $12.5 million so far, SRAX is on track to hit the high end of 2021 guidance, according to CEO Christopher Miglino. For more information, visit the company’s website at www.SRAX.com. NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

Tingo, Inc. (IWBB) Seeks to Combine Commercial Success and Rural Community Empowerment

  • Tingo is an Africa-focused agri-fintech company, which seeks to empower rural farming communities through the introduction of innovative farming solutions
  • In addition to driving shareholder returns, the company has also sought to empower societies and produce social upliftment in rural communities in which it is active
  • The company has adopted 5 core sustainable development goals – food security, poverty alleviation, financial inclusion, employment opportunities, & gender equality
By the end of the first quarter of 2021, assets under management held within ESG (Environment, Social, Governance) focused funds around the world had ballooned to $1.984 trillion, driven by a global drive towards increased sustainability and rising social awareness. Soaring investor demand for assets aligning with their social and ethical concerns have turbo-charged inflows towards sustainable investments; in fact, a study found that 89 cents of every dollar invested within active funds in July 2021 was directed towards ESG-focused funds. Tingo (OTCQB: IWBB), a digital service agri-fintech technology company focused on foundation-level agriculture and related financial services in Africa, has made it its mission to both, support the domestic economies of its host countries and support technological and financial inclusion to reduce poverty levels. Thus, and through its unique business model, Tingo hopes to deliver attractive returns to shareholders while simultaneously, investing in the long-term future of the company and its subsidiaries. Tingo Inc aims to be Africa’s leading agri-fintech player, with a multi-pronged strategy which seeks to provide a roadmap through which to address several key areas of social concern within the African continent. As such, the company has sought to adopt five core sustainable development goals as its corporate mission, namely – ensuring food security, driving poverty alleviation, promoting digital financial inclusion, encouraging job creation, and supporting female entrepreneurship and empowerment. A recent study found that nearly 72 percent of Nigerian smallholder farms survived on less than $1.90 per day, with most living well below the poverty line. Moreover, a significant percentage of the farmers were subject to the vagaries of climate change, an increasingly frequent challenge to the success of their individual harvests. Tingo has sought to both, alleviate poverty levels and address food security through the introduction of new and impactful agri-based farming solutions in a bid to create jobs and uplift incomes for millions of rural farmers in select markets. Alongside their goal to boost employment opportunities within rural areas, Tingo has looked to alleviate poverty and promote digital financial inclusion amongst its millions of stake holders through the disruption of legacy micro-finance industries within the African region. The company has sought to provide its users with a range of innovative financial products, alongside an agri-trading platform and credit solutions, designed to helps farmers market their harvests in a more efficient manner and borrow funds at market rates. Farmers will now be able to access DeFi-stable coins and smart contracts, thereby providing agri-communities access to credit-market driven digital finance solutions to held make them more competitive. Through the company’s proprietary and proven digital technology platforms, Tingo will seek to provide low-cost and dignified mobile transaction services using a dedicated mobile application, thereby lifting a key business barrier to what has historically been a largely underbanked populace. A key tenet underpinning Tingo’s business model has been the company’s steadfast commitment to gender equality. Tingo has looked to encourage female entrepreneurship within Africa’s rural communities through the introduction of training schemes designed to encourage women to operate both, farming and collection businesses. The success of the scheme is best illustrated through Tingo’s burgeoning agent network, which currently consists of approximately 15,000 members – the overwhelming majority of whom are women (https://ibn.fm/qj4GM). In a global economy which is increasingly seeing growing socio-economic differences and competitive pressures, Tingo Inc has sought to create a unique business model which seeks to build out the company as one of Africa’s leading agri-fintech providers while simultaneously, contributing to bettering the lives of millions with Africa’s rural communities. For more information, visit the company’s website at www.TingoGroup.com. NOTE TO INVESTORS: The latest news and updates relating to IWBB are available in the company’s newsroom at https://ibn.fm/IWBB

Lexaria Bioscience Corp. (NASDAQ: LEXX) Improving Bioavailability of Pharmaceuticals and Therapeutics

  • Around 40% of available marketed drugs are poorly bioavailable or soluble, and about 90% of New Chemical Entities are known for their low solubility and permeability
  • Lexaria’s patented DehydraTECH(TM) technology offers a solution by improving how APIs (active pharmaceutical ingredients) enter the bloodstream
  • DehydraTECH achieves this by bypassing first-pass-liver metabolism
  • By doing so, Lexaria is facilitating faster and much more thorough drug delivery
In a report published in the Bioavailability Enhancement Technologies and Services Market, 2018-2030, it was established that around 40% of available marketed drugs are poorly bioavailable or soluble. It was further estimated that approximately 90% of New Chemical Entities (“NCEs”) belong to Biopharmaceutics Classification System (“BCS”) class II and IV, known for their low solubility and permeability (https://ibn.fm/xfrBh). Today, a significant number of drugs fail to reach the market owing to their poor bioavailability. This has prompted companies to re-formulate existing product candidates and explore different tools and methods to try to solve the problem. Lexaria Bioscience (NASDAQ: LEXX) has taken on the challenge and is currently leading the industry in terms of innovation in drug delivery platforms. Its patented DehydraTECH(TM) technology is specifically designed to improve how active pharmaceutical ingredients (“APIs”) enter the bloodstream, ultimately increasing the effectiveness of fat-soluble molecules. Lexaria’s DehydraTECH is a product of years of research and millions of dollars in investments. So far, the technology is covered by 23 issued and over 50 pending patents in 40 different countries worldwide. The demand for solutions is so acute, that more and more companies are offering technologies and/or services geared towards bioavailability enhancement. In addition, several players have even developed novel, industry-leading technologies to maintain a competitive edge in this market that is showing great potential for growth. Lexaria recognized this opportunity back in 2014 and has been investing aggressively into research and the strategic partnerships it has forged so far. Bioavailability can be described as how much an APIcan access the bloodstream within the body. This is typically dependent on absorption as well as secretion. It works on the principle that an API can only offer benefits if it can be absorbed into the body in the first place (https://ibn.fm/8DNGH). One way through which drugs, particularly orally administered ones, have their bioavailability compromised is through first-pass liver processing. Usually, once they are ingested, they must travel from the intestine to the liver for metabolization, before they are circulated within the body and eventually to their targeted area. This arduous process can reduce the amount of drug that actually reaches the bloodstream by as much as twenty-fold inhibiting the effectiveness of the drug itself. Because DehydraTECH bypasses this first-pass liver processing, the drugs begin to reach the bloodstream in as little as two minutes and often reach blood concentration levels between 100% and 200% higher. In addition, given the effectiveness of this technology, patients can also enjoy reduced drug dosing which has the potential to significantly lower the cost of treatment. Lexaria remains committed to exploring new ways through which its DehydraTECH technology can help even more people. So far, it is investigating new products for hypertension, anti-viral treatments, oral nicotine, and other drug classes, with notable progress made so far. The company is also conducting research and development on several critical indications, including epilepsy, dementia, rheumatoid disease, diabetes, human hormones, Ibuprofen and Naproxen (“NSAIDs”), and PDE5 inhibitors. Lexaria understands the value and usefulness of its technology, hence its commitment to further research and partnering with other strategic players within the industry. Its efforts improve the bioavailability of pharmaceuticals and therapeutics, one drug class at a time. For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

Friendable Inc.’s (FDBL) Fan Pass Live Artist Platform December Contest Focuses on Ticketed Streams

  • The artist with the highest number of tickets sold in December will win a $500 cash prize
  • Artists will be able to keep 100 percent of revenue from ticket sales
  • Additional winning opportunities are available for artists who promote at least three events on Instagram
  • A comprehensive guide to setting up ticketed streams is available for artists on the Fan Pass website
Mobile technology and marketing company Friendable (OTC: FDBL) is continuing the tradition of its monthly contest with generous prizes and other revenue-earning opportunities for members of the Fan Pass Live artist platform. For the month of December, the company will reward artists who sell the highest number of tickets via ticketed streaming events organized on the platform. The artist who sells the most tickets will receive a cash prize of $500. The second prize is worth $250, and the third prize is worth $150. An additional $30 bonus is available to artists who will promote three of their ticketed events on Instagram and tag the Fan Pass platform (@fanpasslive) on their posts. Artists will be able to organize and host their ticketed events on Fan Pass completely free of charge and will get to keep 100 percent of their ticket sales. Everyone interested in participating can access a detailed guide to setting up ticketed streaming events on the Fan Pass website (https://ibn.fm/tV3HG). Monthly artist contests are just one of the multiple revenue-generating opportunities artists can leverage on the Fan Pass platform. The revenue structure available for artists who sign up for Fan Pass can help members generate income by selling tickets to private events, selling merchandise, taking part in monthly contests, content views, and more. Since its launch in July 2020, Fan Pass has seen massive growth, with thousands of artist sign-ups in the last 12 months, including both established and independent artists. This year, the platform has reached multiple significant milestones, including the launch of an updated version, the publication of new mobile applications in both the Apple Store and Google Play, and the release of an Artist Pro offering that brings new features and benefits for members, for a monthly subscription of $8.99. Artists who sign up for the Artist Pro option are able to access an advanced dashboard, valuable analytics and marketing services, while also being able to sell custom merchandise and promote scheduled musical events. Fans who subscribe to the platform have the opportunity to gain exclusive access to the artists, allowing them to see their daily lives and get exclusive engagement opportunities, all covered by a highly affordable monthly fee. After the launch of Fan Pass v2.0, the company started monetizing an “ALL ACCESS VIP” offering for fans, available for a monthly subscription of $2.99 or an annual subscription of $25.99. The company goes into 2022 with a commitment to continue expanding its reach and offering to artists and fans alike. According to CEO Robert Rositano Jr., one of the opportunities the company is considering involves artists being included on playlists through partnerships with celebrities, but no specific details are yet available (https://ibn.fm/S1kxg). The company also intends to work toward making Fan Pass a household name, with hundreds of thousands of artists launching their careers and earning revenue via the platform, while also focusing on going global to reach a worldwide audience of artists and fans alike. For more information, visit the company’s websites at www.Friendable.com or www.FanPassLive.com. NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

Attend the NCIA’s 7th Annual Cannabis Business Summit & Expo for an Insightful Experience!

Date: December 15–17, 2021 Venue: Moscone Center San Francisco, 747 Howard St, San Francisco, CA 94103 NCIA’s 7th Annual Cannabis Business Summit & Expo is the premiere national destination for everyone interested in the legal cannabis sector. Join like-minded professionals December 15-17, 2021 at the Moscone Center in San Francisco — the gateway to the Emerald Triangle — to brush up on the latest trends, explore new products and services, and tap into the support of a national network. Also known as #CannaBizSummit, this event is the ideal opportunity to re-energize your business and career. Hosted by the National Cannabis Industry Association (“NCIA”), the largest and oldest national trade association advancing the interests of the cannabis industry, Cannabis Business Summit & Expo is the industry’s most influential national B2B trade show. Gathering over 125 speakers, more than 80 educational sessions, and hundreds of brands, #CannaBizSummit is the only event that brings together an exclusive lineup of education, exhibitors, and experiences under one roof. Furthermore, through networking mixers and after parties, event guests from throughout the country, including licensed merchants, cultivators, cannabis sector business owners, and consumer enthusiasts, will have the opportunity to form significant connections with fellow professionals. Key points to remember:
  • Hundreds of exhibitors will showcase the latest technology, goods, and services. Visitors will be able to shop and compare benefits side by side, plus watch live demos.
  • Expert industry speakers will reveal tricks of the trade and key insights to help individuals future-proof their cannabis business, even in the face of economic and environmental change.
  • Attendees can enjoy the networking mixer, after parties, and gain one-on-one time with suppliers throughout the show, as opportunities to reconnect with colleagues and forge new business relationships.
  • Attend educational sessions covering a range of topics across the entire cannabis ecosystem. On the new Live Podcast Stage, people may also watch live recordings of their favorite podcasts.
  • The new BLOOM: A Brands Experience gives an exciting opportunity to explore cannabis products from brands all over the country.
  • Attend off-site excursions to see how other dispensaries and operations deliver excellent products and services to their customers.
NCIA’s 7th Annual Cannabis Business Summit & Expo will feature the premiere of BLOOM, a “show within a show” that will provide attendees with a unique sensory experience, allowing them to view, touch, and smell items from dozens of brands specializing in flower, vapor, pre-roll, oils, edibles, and more. These vendors will be featured in a custom-designed, easy-to-navigate neighborhood setting. Retailers, infused product manufacturers, distributors, and cultivators with Cultivators with an active state license may attend the Expo, Keynote Sessions, and General Sessions on a complimentary basis. Additional ticketing options start at $59. For more information, please visit https://ibn.fm/ZUMXO

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Finishing Up Significant 2021 Calendar Year

  • 2021 marked Mydecine’s patent application for its MYCO-003 drug candidate
  • It also marked notable clinical trials on various aspects, including smoking cessation
  • Mydecine also got into a 5-year research agreement with JHU for clinical research on the use of psychedelics for therapeutics
  • These milestones have laid down the groundwork, not just for Q3 of the 2021 financial year but also for the company’s growth in the 2022 calendar year
Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA), since its inception in 2020, has been aiming to transform the treatment of mental health disorders and addiction through biotechnology. The company has already developed first and second-generation novel therapeutics geared towards treating addiction, post-traumatic stress disorder (“PTSD”), and other mental health disorders. Mydecine recently released its third-quarter 2021 update and a noteworthy announcement for the 2021 calendar year. It offers a glimpse into achievements to date, and what stakeholders can anticipate in the last quarter of the 2021 financial year and for the 2022 calendar year (https://ibn.fm/OnAyi). Most notably, Mydecine filed a patent application for its MYCO-003 drug candidate to treat PTSD and anxiety. It also filed a new patent for MDMA-like compounds, as well as a technology patent for the creation of formulations that use nano-emulsion technologies to enhance, stabilize and make repeatable properties of ingredients from traditional medicine. These and other patent applications are helping to expand Mydecine’s robust portfolio of novel compounds while also increasing value to shareholders. Going into the last quarter of the 2021 fiscal year, Mydecine is proud to commence with its 5-year research agreement with John Hopkins University (“JHU”) School of Medicine for clinical research related to the use of psychedelics for therapeutics. The company is also excited to proceed with MYCO-001, one of its lead candidates, through Phase 2/3 clinical trials for smoking cessation. It is projected that by 2026, the smoking cessation market will be valued at $63.99 billion, representing a CAGR of 16.9% over the forecast period- 2018-2026 (https://ibn.fm/AJSJJ). On the other hand, the psychedelic therapeutics market is estimated to be valued at $6.5 billion by 2030, representing a CAGR of 15% over the forecast period- 2018-2030. With the growing popularity and interest in psychedelic therapeutic drugs, Mydecine has recognized an opportunity in this segment. This is evidenced by its investment in clinical trials and its advancements with its technologies. From the groundwork laid down over the 2021 calendar year, it is projected that 2022 will be a big year for Mydecine, and offers hope to those suffering from mental health and addiction disorders. For more information, visit the company’s website at www.Mydecine.com. NOTE TO INVESTORS: The latest news and updates relating to MYCOF are available in the company’s newsroom at https://ibn.fm/MYCOF

Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF) Adds Three New iGaming Operators with Double-Digit Growth Across Multiple Indicators

  • PLGNF adds three iGaming operators to platform, additional eight at testing and integration stages
  • Growth indicators from November include 12% player wager increase, 28% active player growth, 22% increase in bet spots
  • PLGNF’s proprietary technology enables seamless integration at operator level, allows user access without sharing sensitive data or requiring app store download.
  • PLGNF has a typical SaaS business model which includes zero player acquisition cost.
  • Grandview Research forecasts global online gambling market to reach $127.3 billion by 2027, CAGR of 11.5% from 2020 to 2027
Playgon Games (TSX.V: DEAL) (OTCQB: PLGNF), a propriety SaaS technology company delivering live dealer mobile technology to global online gaming operators, recently announced the addition of three new operators to its platform, bringing the total to 26. The company also reported that critical key performance indicators were up for November, including 12% growth in player wagering, a 28% increase in monthly active player numbers, and 22% growth in bet spots (https://ibn.fm/iw6zA). “We continue to garner strong interest and onboard operators rapidly as the demand for our product continues to grow at a healthy pace,” said Darcy Krogh, CEO of Playgon Games. “Player activity and wagering are important metrics of the success of our mobile live dealer product, and we are delighted with the growth we are experiencing. For the second month in a row, we are delivering record increases in player wagering, which is a direct function of the growing number of users leveraging our platform as we offer our games through some of the largest gaming operators globally.” PLGNF’s iGaming software provides a multi-tenant gateway that allows global online operators to deliver an authentic casino experience streamed live from Las Vegas. Games include Live Dealer Casino, E-Table Games and Daily Fantasy Sports. Their Live Casino is presented with high-definition live streaming dealers and state-of-the-art augmented reality technology that gives users a best-in-class user experience without sharing sensitive data or requiring an app store download. The company expects the growth trend to continue driven by 4 key pillars, the pandemic, new regulation, technology, and user demographic. “As we look ahead to the new year, we anticipate continued growth in client acquisition and player activity with a material number of new operators coming online and ultimately strong revenue growth,” said Krogh. “We are confident in our strategy and look forward to continued growth and success.” Krogh was recently featured on the Investor Brand Network’s Bell2Bell podcast, where he revealed details about the company’s successful growth strategy in addition to insights into the massive expansion being seen in the iGaming sector (https://ibn.fm/7BVYU). “We’re 80 strong with employees, including 20 engineers, with our core product being live dealer table games. We have 60 dealers in our studio in Las Vegas who deliver the content to our customers. We are a growing, publicly-traded, Malta-licensed, mobile-focused development company in a high growth industry.” Grandview Research forecasts the global online gambling market to reach $127.3 billion by 2027, at a CAGR of 11.5% from 2020 to 2027 (https://ibn.fm/BQw4G). Factors such as innovations in artificial intelligence and machine learning, increased options for digital payments, and an expanding female segment are all expected to contribute to market growth. PLGNF is positioned favorably with its portfolio of IP-protected assets, high barriers to entry, and decades of management experience with multiple successful exits. For more information, visit the company’s website at www.Playgon.com. NOTE TO INVESTORS: The latest news and updates relating to PLGNF are available in the company’s newsroom at https://ibn.fm/PLGNF

FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) Development of Green Ammonia IP Significantly Boosts Potential of Alternative Fuel Source

  • Canadian-based clean energy solutions innovator FuelPositive Corp. is focused on developing green ammonia as a more efficient and sustainable source of fuel than the popular fossil fuel alternative hydrogen
  • FuelPositive’s Hydrogen-Ammonia Synthesizer technology provides the means of storing hydrogen as green ammonia for effective transportation and storage, with the option of easy conversion back to hydrogen for use in hydrogen fuel cells and other pure hydrogen applications
  • The company is among a handful of entities that have noted Canada’s outsized support for fossil fuels recently, and plans to roll out its IP next year in “real world” demonstration pilot projects
  • Carbon footprint reduction has gained global attention in recent years amid concerns about climate change resulting from pollutants, and policy representatives from around the world recently gathered in Scotland for the COP26 2021 United Nations Climate Change Conference to address related issues
When green energy innovator FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) commissioned an analysis of Canada’s green off-peak electricity capacity earlier this year to help measure the fuel needs and carbon emissions of the country’s transportation sector, FuelPositive was adding its own insights to a recent series of examinations of Canada’s renewable energy performance. Oil Change International, which tracks public finance of fossil fuels, reported last month that Canadian fossil fuel producers receive more public financial support than any others in the developed world, and that Canadian renewable energy received far less in public financial support than many other countries provide to their industries (https://ibn.fm/434r3). The report noted that both the federal government and Export Development Canada — the agency that handles most of the financing — have pledged they’ll reduce fossil fuel financing during the coming years, with the Liberal party setting a deadline of 2023. Export Development Canada expects to reduce support to the six most carbon-intensive sectors by 40% below 2018 levels before the deadline, according to the report. FuelPositive is in the business of developing and commercializing green energy solutions and gaining standout technology innovation in the sector through partnerships and acquisition, specifically in regard to “green ammonia” produced in a carbon-free manner for use in a variety of applications that contribute to environmental sustainability at a time when climate change is a profound concern for world governments. FuelPositive’s patent-pending green ammonia (“NH3”) technology is an advanced Hydrogen-Ammonia Synthesizer, a highly portable and scalable and modular system the company plans to introduce next year in “real world” demonstration pilot projects as it advances toward commercial production (https://ibn.fm/QPvbF). Carbon-free green ammonia has the potential to become a fossil fuel alternative — the company notes that planes, trains, ships, trucks, and other vehicles can be converted to run on ammonia as easily as they can be converted to run on propane instead of gasoline or diesel. Additionally, FuelPositive’s Hydrogen-Ammonia Synthesizer technology can convert air, water, and sustainable electricity to store hydrogen in the form of green ammonia, allowing hydrogen to be more efficiently stored or transported than it would be in liquid hydrogen form which requires high-pressure tanks and cryogenic storage temperatures. An end user can then easily convert the green ammonia back into hydrogen for use in producing electricity in a hydrogen fuel cell when that is required by transportation vehicles, according to the company. FuelPositive is also pursuing the development of green ammonia fuel cells which are a new and attractive alternative to hydrogen fuel cells. Following the latest international climate summit, branded COP26, many researchers have described hydrogen as the best source for generating renewable energy (https://ibn.fm/SRSx5) because when hydrogen burns, the only by-product is water. But hydrogen has traditionally been generated from fossil fuels, which only compounds the challenges of developing clean energy goals. Former California Gov. Arnold Schwarzenegger was expected to attend the COP26 2021 United Nations Climate Change Conference talks, which concluded Nov. 12, and appeared in the news prior to the summit as part of a wide-ranging interview in which he criticized some of the excuses policy advisers use for resisting transition to sustainable fuel sources. “They are liars, they are stupid. Or they don’t know how to do it, because we figured how to do it (in California),” Schwarzenegger told the BBC (https://ibn.fm/iFNDp). Schwarzenegger has built his own brand on performance fitness celebrity over the past several decades and, more recently, on environmental sustainability goals. He told the interviewer he was particularly alarmed at pollutants that result from shipping and suggested shopping locally is the most important thing individuals can do to cut carbon emissions. “Buy local products. Every time you buy something from overseas, that is evil for the environment — this is like the worst thing you can do. … You can have (international) competition but you have to be smart about it … because if people are dead, they are dead. It’s over.” For more information, visit the company’s website at www.FuelPositive.com. NOTE TO INVESTORS: The latest news and updates relating to NHHHF are available in the company’s newsroom at https://ibn.fm/NHHHF

From Our Blog

Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF): Anticipating Tomorrow’s Imaging Standards Today

September 26, 2025

In medical imaging, technology often races ahead of regulation. A recent proposal from the Centers for Medicare & Medicaid Services (CMS) underscores this tension: the agency is opting not to mandate radiation dose tracking for CT scans by 2027. While the decision reflects operational challenges hospitals face in meeting such requirements, it also highlights a […]

Rotate your device 90° to view site.